HIV could be treated with a once-a-week pill
HIV therapy involves a combination of drugs that must be taken once or twice daily, making treatment adherence challenging for many...
How tuberculosis hides in the body
Tuberculosis bacteria hide in the very cells that would normally kill them. Now we know more about how they evade recognition....
Cenicriviroc May Reduce Fibrosis In People With Fatty Liver Disease
Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, was associated with a decrease in liver fibrosis in people...
Sofosbuvir Reduces Transplant Need and Mortality Rates in Hepatitis C Patients, Study Finds
Sofosbuvir (sold under the brand name Sovaldi from Gilead Sciences, among others) significantly reduces the risk of death and the need...
Study Offers New Strategy for HIV Vaccine
Sugar molecules that perform an “anchor” function could be critical in the development of a vaccine against HIV, according to a new study....
HIV cases among gay and bisexual men drop for the first time as experts hail 'significant advanc
New cases of HIV have fallen among gay and bisexual men for the first time, thanks partly to a controversial new drug labelled a...
Joint United Nations statement on ending discrimination in health care settings
United Nations entities recall that a central principle of the 2030 Agenda for Sustainable Development is to “ensure that no one is left...
Prince Harry hits out at 'absurd' lack of youth education on HIV
Prince Harry slammed the lack of youth education about HIVas "totally absurd" during a visit to London School of Hygiene and Tropical...
HIV prevention drug PrEP to be made available for thousands of NHS patients from September
A new HIV prevention drug will be made available for free to thousands of NHS patients in September, The pioneering PrEP - or...
HIV in the UK: Why we're still facing an epidemic and trials are not enough
One in seven gay and bi men in London lives with HIV. The number of new diagnoses in the UK is nearly double the average of Western...
HIV/AIDS is no longer the leading cause of death in Africa
The World Health Organization’s most recent data on global deaths has good news for the African continent, including fewer people dying...
The sex workers who are leading the fight against HIV in Mozambique
It’s late when we reach Inhamízua on the outskirts of the city. Stalls sell crackling chicken feet and sizzling plantain. Scores of men...
Global Fund gives Kenya Sh33b for HIV/AIDS, malaria and TB
Kenya has received Sh33 billion from the Global Fund to boost the war against HIV/AIDS, malaria, and tuberculosis. The grant came after...
TB: Genetic drug resistance tests as good in gauging treatment outcome, death risk as traditional cu
Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs....
Closing an HIV lifeline in Africa: the dire impact of Trump's abortion crackdown
Celeste is a 30-year-old widow mother of two from the poor suburbs of Maputo, Mozambique’s capital. She is HIV-positive, and since her...
Cattle could hold the key to defeating HIV virus
Cattle have a "mind blowing" ability to combat the HIV virus, American researchers have found. Scientists believe that a cow's complex...
Child treated for HIV at birth is healthy nine years on without further treatment
A child who was infected with HIV at birth and given a short course of treatment has remained healthy for the last nine years without...
Monthly shot could be the ‘next revolution’ in HIV therapy, replacing daily pills
The 9th International AIDS Society conference has drawn thousands of researchers to Paris this week. HIV/AIDS is no longer the death...
Viral load as low as 400 copies/ml six months after starting ART is associated with a significant te
A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk,...





